Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Change in Receivables (2020 - 2026)

Treace Medical Concepts filings provide 6 years of Change in Receivables readings, the most recent being $9.5 million for Q4 2025.

  • On a quarterly basis, Change in Receivables fell 44.64% to $9.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.1 million, a 63.25% decrease, with the full-year FY2025 number at $2.1 million, down 63.25% from a year prior.
  • Change in Receivables hit $9.5 million in Q4 2025 for Treace Medical Concepts, up from $2.6 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $17.2 million in Q4 2024 to a low of -$9.3 million in Q1 2025.
  • Median Change in Receivables over the past 5 years was -$133000.0 (2022), compared with a mean of $1.6 million.
  • Biggest five-year swings in Change in Receivables: tumbled 369.82% in 2021 and later soared 343.49% in 2023.
  • Treace Medical Concepts' Change in Receivables stood at $7.0 million in 2021, then surged by 59.14% to $11.1 million in 2022, then grew by 20.95% to $13.4 million in 2023, then grew by 28.09% to $17.2 million in 2024, then tumbled by 44.64% to $9.5 million in 2025.
  • The last three reported values for Change in Receivables were $9.5 million (Q4 2025), $2.6 million (Q3 2025), and -$696000.0 (Q2 2025) per Business Quant data.